Aug 29, 2025 A Practical Guide to Interpreting Pulmonary Function Tests
When patients present with symptoms like persistent coughing, unexplained shortness of breath, or chronic wheezing, every moment counts in identifying the underlying cause. Complete Pulmonary Function Tests (PFTs) offer a fast, reliable path to diagnostic clarity. A structured interpretation of spirometry, lung volumes, and diffusing capacity (DLCO) results transforms vague respiratory complaints into actionable diagnosis. Here’s how to make each data point count toward better patient outcomes.
Step 1: Start with Spirometry: Detecting Obstructive Patterns
Spirometry is the first line of investigation. If the FEV1 is reduced and the FEV1/FVC ratio is low, it signals an obstructive ventilatory defect. A low FEF25-75 supports small airway involvement, further pointing toward conditions like asthma or early COPD.
To confirm asthma, administer a bronchodilator and evaluate for reversibility:
- A ≥12% improvement in FEV1
- A ≥20% improvement in FEF25-75
If spirometry is inconclusive, a methacholine challenge test can help confirm airway hyperresponsiveness by detecting a ≥15-20% decrease in FEV1.
Step 2: Evaluate FVC: A Window into Restrictive Defects
A reduced FVC may suggest a restrictive ventilatory pattern. However, ensure patient effort was optimal by reviewing the peak expiratory flow (PEF). Low PEF could indicate insufficient effort, which may mask or falsely suggest restriction.
Step 3: Add Lung Volumes: Identifying Trapping or True Restriction
If FEV1 appears normal but suspicion remains, assess lung volumes:
- Elevated residual volume (RV) signals air trapping, common in obstructive diseases.
- Reduced total lung capacity (TLC) confirms restrictive defects, particularly in cases of interstitial lung disease or chest wall deformities.
Step 4: Leverage DLCO: Distinguishing Intrapulmonary vs. Extrapulmonary Causes
DLCO testing provides critical insights into gas exchange efficiency and helps clinicians pinpoint the origin of restrictive or mixed defects:
- Normal DLCO may indicate extrapulmonary causes such as obesity or neuromuscular disorders.
- Reduced DLCO suggests intrapulmonary pathologies like interstitial lung disease, emphysema, or pulmonary vascular disorders.
By understanding these distinctions, clinicians can diagnose earlier and tailor treatment more precisely. This is especially important in progressive conditions like idiopathic pulmonary fibrosis or COPD.
Recognizing Complex Patterns
Not all cases follow textbook presentations. Clinicians should stay alert to these nuanced patterns:
- Obstruction with low DLCO may indicate emphysema.
- Normal spirometry and lung volumes with low DLCO may point toward anemia, early ILD, or pulmonary vascular disease.
- Elevated DLCO is seen in asthma, obesity, polycythemia, or intrapulmonary hemorrhage.
Simplifying Complete PFT Testing and Interpretation
Recognizing the clinical challenges of pulmonary diagnostics, PulmOne developed the MiniBox+ to bring precision, portability, and patient comfort to the forefront of respiratory care. This compact, cabinless device enables clinicians to perform complete PFTs, including spirometry, lung volumes, and DLCO, quickly and easily in the office without requiring outsourced testing.
For practices focused on efficiency and continuity of care, the MiniBox+ is a transformative tool that accelerates diagnosis, eliminates testing delays, and supports on-the-spot clinical decisions.
Enhancing Clinical Confidence in Complex Cases
By following a structured approach, starting with spirometry and continuing with lung volumes and DLCO according to the symptoms presented, clinicians can build a complete picture of a patient’s respiratory function. With the MiniBox+, this process becomes faster, more comfortable, and more insightful for both patients and providers.